TEVA - Teva Pharmaceutical Industries Limited Stock Price and Quote

TEVA [NYSE]

Index	-	P/E	-	EPS (ttm)	-2.12	Insider Own	2.00%	Shs Outstand	1.11B	Perf Week	-4.59%
Market Cap	9.75B	Forward P/E	3.38	EPS next Y	2.52	Insider Trans	-1.82%	Shs Float	1.10B	Perf Month	-15.54%
Income	-2352.00M	PEG	-	EPS next Q	0.56	Inst Own	49.60%	Short Float / Ratio	2.32% / 2.91	Perf Quarter	-4.80%
Sales	14.93B	P/S	0.65	EPS this Y	-662.70%	Inst Trans	9.06%	Short Interest	25.57M	Perf Half Y	-3.18%
Book/sh	7.10	P/B	1.20	EPS next Y	4.86%	ROA	-5.20%	Target Price	10.15	Perf Year	8.25%
Cash/sh	2.45	P/C	3.48	EPS next 5Y	3.60%	ROE	-26.80%	52W Range	6.78 - 11.44	Perf YTD	-6.47%
Dividend	-	P/FCF	9.36	EPS past 5Y	34.30%	ROI	-5.00%	52W High	-25.47%	Beta	1.22
Dividend %	-	Quick Ratio	0.70	Sales past 5Y	-7.80%	Gross Margin	49.80%	52W Low	25.83%	ATR	0.29
Employees	34004	Current Ratio	1.10	Sales Q/Q	-5.30%	Oper. Margin	-14.10%	RSI (14)	28.67	Volatility	3.03% 2.48%
Optionable	Yes	Debt/Eq	2.69	EPS Q/Q	-660.40%	Profit Margin	-15.80%	Rel Volume	2.22	Prev Close	8.36
Shortable	Yes	LT Debt/Eq	2.42	Earnings	Feb 08 BMO	Payout	-	Avg Volume	8.79M	Price	8.53
Recom	3.10	SMA20	-10.48%	SMA50	-15.79%	SMA200	-6.00%	Volume	19,468,374	Change	2.03%

Jan-19-23

Downgrade

Jefferies

Buy → Hold

$10 → $12

Nov-14-22

Downgrade

JP Morgan

Neutral → Underweight

$11 → $10

Nov-04-22

Downgrade

UBS

Neutral → Sell

Oct-21-22

Resumed

Jefferies

Buy

$10

Aug-05-22

Upgrade

BofA Securities

Neutral → Buy

$10 → $13

Jun-14-22

Resumed

UBS

Neutral

$10

May-17-22

Upgrade

BofA Securities

Underperform → Neutral

May-04-22

Downgrade

Piper Sandler

Neutral → Underweight

$11 → $7

Apr-05-22

Upgrade

Barclays

Equal Weight → Overweight

$11 → $13

Mar-25-22

Upgrade

Bernstein

Mkt Perform → Outperform

$11

Show Previous Ratings

Mar-17-23 05:54PM	15 Best Stocks Under $10 To Buy Now Insider Monkey
Mar-14-23 10:20PM	25 Biggest Pharmaceutical Companies in the World Insider Monkey
Mar-13-23 09:54AM	McKinsey Consulted VA While Advising Opioid Makers to Target Agency for Sales The Wall Street Journal
09:33AM	Teva Announces Early Tender Results of its Debt Tender Offer, Increases to Tender Caps and Election of Early Settlement Business Wire
Mar-09-23 08:00AM	Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S. Business Wire
04:00PM	Loading…
Mar-07-23 04:00PM	Teva to Present at the Barclays Global Healthcare Conference Business Wire
Mar-05-23 11:28AM	Better Generics Pharmaceutical Stock: Teva or Viatris? Motley Fool
Mar-03-23 11:01AM	3 Generic Drug Stocks to Watch Amid Macro Headwinds Zacks
12:16AM	Q4 2022 Alvotech SA Earnings Call Thomson Reuters StreetEvents
Mar-01-23 04:11PM	Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent) Sustainability-Linked Senior Notes and the Increase of the Maximum Tender Amount of its Debt Tender Offer Business Wire
Feb-27-23 03:30AM	Teva Announces Launch of $2,060,000,000 (Equivalent) Offering of Sustainability-Linked Senior Notes Business Wire
03:30AM	Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026 Business Wire
Feb-24-23 08:00AM	Teva to Present New Data from CONNECT2 Study on its Digihaler® System at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual Meeting Business Wire
Feb-23-23 08:00AM	Teva Announces Publication of New Clinician Scale in Journal of Clinical Psychiatry to Assess the Impact of Tardive Dyskinesia on Patients Lives Business Wire
Feb-22-23 07:32AM	15 Best Value Stocks to Buy According to Legendary Bill Miller Insider Monkey
04:56PM	Loading…
Feb-17-23 04:56PM	Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets Business Wire
Feb-13-23 05:31PM	Teva Plots Its Knockoff Of Axsome's New Depression Drug, Sending The Biotech Sprawling Investor's Business Daily
08:01AM	Axsomes stock falls after disclosing Tevas plans to market generic Auvelity MarketWatch
Feb-09-23 02:29PM	Vanda Pharmaceuticals seeks multiple FDA approvals while battling generic competition American City Business Journals
02:24PM	Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2022 Earnings Call Transcript Insider Monkey
08:29AM	TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down Zacks
08:00AM	Teva Reaches Agreement With Florida to Settle the States Price Fixing Claims Business Wire
Feb-08-23 04:30PM	Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript Motley Fool -8.91%
04:09PM	Teva Guides To Its First Year Of Growth Since 2017 But Shares Tumbled On This Caveat Investor's Business Daily
12:01PM	Why Teva Pharmaceutical Stock Is Sliding Today Motley Fool
11:58AM	Teva Pharma Posts Lower Q4 Earnings, FY23 Outlook Within Expectations Benzinga
08:53AM	Teva Pharmaceutical Stock Dives On Fourth-Quarter Miss, Light 2023 Guidance Investor's Business Daily
07:00AM	Teva Reports Fourth Quarter and Full Year 2022 Financial Results Business Wire
05:21AM	Nasdaq Bear Market: 3 Tantalizing Value Stocks That Can Double Your Money by 2026 Motley Fool
Feb-03-23 01:19PM	10 Hot Healthcare Stocks To Buy Now Insider Monkey
01:33PM	Loading…
Jan-31-23 01:33PM	Analyst Report: Teva Phar Inds Lt Argus Research
01:18PM	Market Update: TEVA, ADM, MCD, RJF, SANM, NXPI Argus Research
Jan-27-23 09:40AM	Is Teva Pharmaceutical Industries (TEVA) a Great Value Stock Right Now? Zacks
Jan-26-23 09:22AM	Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed? Motley Fool
Jan-25-23 10:53AM	Biotech Stock Roundup: BLUE Down on Share Issuance, CPRX Falls on Generic Filing & More Zacks
05:21AM	Nasdaq Bear Market: 3 Screaming Bargains That Can Double Your Money by 2025 Motley Fool
Jan-24-23 12:26PM	Catalyst (CPRX) Down on TEVA's FDA Filing for Firdapse Generic Zacks
Jan-23-23 04:11PM	No. 1 IBD 50 Stock Catalyst Tanks As Teva Looks To Knock Off Its Only Product Investor's Business Daily
11:30AM	Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product Benzinga
Jan-19-23 07:00AM	Tevas Ambitious Climate Targets Externally Validated by the Science Based Targets initiative (SBTi) Business Wire
Jan-14-23 06:15AM	3 Dirt Cheap Stocks to Buy in January Motley Fool
Jan-12-23 04:30PM	Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023 Business Wire
Jan-10-23 10:03AM	TEVA Shares Rise on Broad Support for Opioids Settlement Zacks
Jan-09-23 08:34AM	UPDATE 1-Teva says opioids settlement to move forward in U.S. Reuters
08:22AM	Teva says opioids settlement to move forward in U.S Reuters
08:19AM	Teva Pharmaceutical Industries Ltd. (TEVA) Stock Jumps 5.5%: Will It Continue to Soar? Zacks
08:00AM	Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States Business Wire
Jan-06-23 07:00AM	Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) Business Wire +5.52%
04:00AM	Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) GlobeNewswire
Jan-04-23 01:24PM	Teva Pharmaceutical Rallies, So Let's Adjust Our Bullish Strategy TheStreet.com +5.14%
Jan-03-23 04:30PM	Teva to Present at the 41st Annual J.P. Morgan Healthcare Conference Business Wire
Dec-30-22 06:15AM	2 "Safe" Stocks That Are Anything But Motley Fool
Dec-22-22 04:00AM	Update on U.S. Regulatory Status of AVT02, Alvotechs Proposed High-Concentration, Interchangeable Biosimilar to Humira® GlobeNewswire
Dec-21-22 05:21AM	My Top 5 Portfolio Holdings for 2023 Motley Fool
Dec-20-22 08:38AM	Teva Pharmaceutical Industries (NYSE:TEVA investor five-year losses grow to 55% as the stock sheds US$600m this past week Simply Wall St.
Dec-07-22 11:08AM	Emergent (EBS) OTC Narcan Filing Gets FDA Priority Review Tag Zacks
Dec-05-22 05:21AM	3 Unparalleled Stocks to Buy That Have Never Been This Cheap Motley Fool
Nov-27-22 12:06PM	Hedge funds and C-suites weekly: Bob Iger's return to Disney Investing.com
10:00AM	Worlds Top-Selling Drug Going Off Patent Means Big Bucks for Middlemen The Wall Street Journal
Nov-23-22 08:58AM	Teva Pharmaceutical Is Bottoming: Here's My Strategy TheStreet.com
Nov-22-22 03:01PM	AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits Benzinga
02:53PM	UPDATE 1-FOCUS-Generic drugmakers Teva and Sandoz make major push to biosimilars Reuters
11:30AM	Teva, AbbVie finalize $6.6 billion U.S. opioid settlements Reuters
11:25AM	Teva, AbbVie finalize $6.6 billion U.S. opioid settlements Reuters
10:05AM	Teva Pharmaceutical (TEVA) Names Richard Francis as New CEO Zacks
08:30AM	Teva Finalizes Nationwide Opioid Settlement Terms Business Wire
06:00AM	CORRECTED (OFFICIAL) -FOCUS-Generic drugmakers Teva and Sandoz make major push to biosimilars Reuters
Nov-21-22 10:13AM	Teva Pharmaceutical Names Richard Francis as CEO, President The Wall Street Journal
07:38AM	UPDATE 3-Teva hires ex-Novartis executive to succeed CEO Schultz Reuters
07:16AM	Teva names former Sandoz chief Richard Francis as new CEO MarketWatch
07:00AM	Teva Announces Appointment of Richard Francis as President and CEO Business Wire
01:43AM	10 analyst pans to watch: Coinbase cut after FTX crash Investing.com
Nov-16-22 06:40AM	Top 10 Stocks to Buy According to David Abramss Abrams Capital Management Insider Monkey
Nov-14-22 05:02PM	Analysts are Downgrading These 10 Stocks Insider Monkey
08:01AM	Teva Announces Unique Collaboration with Rimidi to Expand the Reach of its Respiratory Digital Health Platform Business Wire
08:00AM	Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform Business Wire
Nov-10-22 08:19AM	Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M Benzinga
Nov-09-22 04:32PM	Eli Lilly ordered to pay $176.5 million to Teva in U.S. migraine drug patent trial Reuters
04:30PM	Eli Lilly ordered to pay $176.5 mln to Teva in U.S. migraine drug patent trial Reuters
05:37AM	Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations Simply Wall St.
05:21AM	Adding $100 to These 5 Stocks Would Be a Genius Move Right Now Motley Fool
Nov-07-22 04:30PM	Teva to Present Latest Research from the CONNECT1 and CONNECT2 Clinical Trials at the American College of Allergy, Asthma & Immunology (ACAAI) 2022 Annual Scientific Meeting Business Wire +5.43%
Nov-04-22 06:03PM	Why Teva Stock Stumbled Again on Friday Motley Fool
10:45AM	TEVA Misses on Q3 Earnings, Cuts 2022 Sales View, Stock Down Zacks
Nov-03-22 05:57PM	Why Teva Stock Sank On Thursday Motley Fool
04:24PM	Teva Pharmaceutical to Replace CEO Kare Schultz The Wall Street Journal
12:30PM	Teva Pharmaceutical Industries (TEVA) Q3 2022 Earnings Call Transcript Motley Fool
12:28PM	Teva Is on the Way to Leaving Opioid Litigation Behind, CEO Says Barrons.com
09:37AM	UPDATE 2-Teva to pay $523 mln to New York as it looks to move past opioid lawsuits Reuters
09:37AM	UPDATE 1-Teva Pharm to pay $523 mln to New York State to settle opioid lawsuit Reuters
08:55AM	Teva Pharmaceutical Posts Lower Q3 Sales & Profits, Trims FY22 Revenue Outlook Benzinga
08:25AM	Teva to pay up to $4.2 billion in U.S. to settle opioid claims Reuters
07:47AM	Teva to pay $523 million to New York as it looks to move past opioid lawsuits Reuters
07:47AM	Teva Pharm to pay $523 million to New York State to settle opioid lawsuit Reuters
07:00AM	Teva Reports Third Quarter 2022 Financial Results Business Wire
Nov-02-22 09:25AM	Drug, Biotech Stocks' Q3 Earnings on Nov 3: AMGN, REGN & More Zacks
Oct-28-22 06:01PM	Teva Pharmaceutical Industries Limited stock performance and analyst projections Yahoo Finance Video
Oct-27-22 07:19PM	11 Best Very Cheap Stocks To Buy Now According To Hedge Funds Insider Monkey
Oct-25-22 10:00AM	Clinics Across Florida, New Jersey & California Advancing Mental Health in Underserved Communities Awarded Funding from Teva Pharmaceuticals, Direct Relief and NAFC Business Wire
Oct-21-22 06:02PM	Teva Pharmaceutical Industries Limited stock performance and analyst projections Yahoo Finance Video

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also manufactures and sells active pharmaceutical ingredients, as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory, and oncology areas. The company's products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dethlefs Sven	EVP, North America Commercial	Mar 07	Sale	9.43	58,066	547,440	165,381	Mar 08 04:03 PM
Daniell Richard	Exec. VP, European Commercial	Mar 07	Sale	9.43	54,007	509,173	69,770	Mar 08 04:02 PM
Stark David Matthew	Exec. VP Chief Legal Officer	Mar 07	Sale	9.43	49,475	466,445	2,974	Mar 08 04:05 PM
Drape Eric	Executive VP Global Operations	Mar 07	Sale	9.43	4,699	44,302	173,262	Mar 08 04:04 PM
Dethlefs Sven	EVP, North America Commercial	Mar 06	Sale	9.93	19,355	192,213	223,447	Mar 08 04:03 PM
Daniell Richard	Exec. VP, European Commercial	Mar 06	Sale	9.93	18,002	178,776	123,777	Mar 08 04:02 PM
Stark David Matthew	Exec. VP Chief Legal Officer	Mar 06	Sale	9.93	16,491	163,770	52,449	Mar 08 04:05 PM
Drape Eric	Executive VP Global Operations	Mar 06	Sale	9.93	1,566	15,552	177,961	Mar 08 04:04 PM
Stark David Matthew	Exec. VP Chief Legal Officer	Feb 28	Sale	9.89	63,383	626,642	2,974	Mar 02 07:38 AM
Dethlefs Sven	EVP, North America Commercial	Feb 28	Sale	9.89	59,655	589,785	165,381	Mar 02 07:33 AM
Daniell Richard	Exec. VP, European Commercial	Feb 28	Sale	9.89	44,252	437,502	43,182	Mar 02 07:33 AM
Drape Eric	Executive VP Global Operations	Feb 28	Sale	9.89	33,685	333,030	87,789	Mar 02 07:34 AM
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	Aug 22	Sale	10.07	55,500	558,696	9,376	Aug 24 07:50 AM
Stark David Matthew	Exec. VP Chief Legal Officer	Jul 28	Sale	9.04	58,163	525,590	2,974	Jul 29 07:02 AM
Fridriksdottir Hafrun	Executive VP, Global R&D	May 17	Sale	8.22	130,000	1,068,067	1,387	May 19 07:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience